Case ReportDeep Intrastromal Bevacizumab Injection for Management of Corneal Stromal Vascularization After Deep Anterior Lamellar Keratoplasty, A Novel TechniqueHashemian, Mohammad Naser MD; Zare, Mohammad Ali MD; Rahimi, Firoozeh MD; Mohammadpour, Mehrdad MDAuthor Information From the Cornea Department, Eye Research Center, Farabi Eye Center, Tehran Medical University, Qazvin Square, Tehran, Iran. Received for publication May 18, 2009; revision received February 8, 2010; accepted February 17, 2010. There is no financial interest for the authors in any methods or materials mentioned in this article. Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.corneajrnl.com). Reprints: Mehrdad Mohammadpour, Cornea Department, Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran 55400010, Iran (e-mail: [email protected]). Cornea: February 2011 - Volume 30 - Issue 2 - p 215-218 doi: 10.1097/ICO.0b013e3181e291a6 Buy SDC Metrics Abstract Purpose: To report the effect of intrastromal injection of bevacizumab in an eye with extensive corneal stromal vascularization after deep anterior lamellar keratoplasty. Methods: Bevacizumab (2.5 mg/1 mL) was injected into the deep corneal stroma of an eye with severe and extensive stromal vascularization. Results: Corneal vascularization regressed dramatically after deep stromal injection of bevacizumab with no recurrence after 6 months. Visual acuity was improved, and the patient's complaints subsided. Conclusions: Corneal intrastromal injection of bevacizumab can be considered for management of intrastromal vascularization after deep anterior lamellar keratoplasty. Copyright © 2011 Wolters Kluwer Health, Inc. All rights reserved.